Industry Briefs: June 11, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: June 11, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Adventrx Pharmaceuticals and Pierre Fabre Medicament have entered into a manufacturing agreement for ANX-188 drug substance. Read More

Almac and VTU Technology have formed a collaboration for joint-services for site-specification modification and labeling, such as PEGylation. Read More

Analytical Solutions has changed its name to Tergus Pharma to reflect its expanded services in dermatology product development. Read More

Anderson Packaging and Brecon Pharmaceuticals have announced plans to realign the companies’ businesses to form a full-service pharmaceutical packaging company, under the name AndersonBrecon. Read More

Michael Valazza, vice-president in Catalent’s Modified Release Technologies business will conduct a workshop on “Coordination of Activities and Responsibilities for Solid Dosage Forms” at the Pharmaceutical Technology Transfer Course being held in Amsterdam, the Netherlands on June 13–14, 2012. Read More

Cobra Biologics and Alligator Bioscience have announced that they have entered into a manufacturing services and supply agreement for the production of a monoclonal antibody drug substance and product for preclinical studies and Phase I–II clinical trials. Read More

GlaxoSmithKline has successfully used Capsugel’s Licaps liquid-filled hard capsules for Granu Fink, a product line in the German urological market. Read More

The Johnson & Johnson subsidiary Animas has announced positive results from the first human clinical trials of a first-generation artificial pancreas system for treating Type I diabetes. Read More

Maxxam Analytics has acquired Becquerel Laboratories. Read More

MeadWestvaco has acquired the Aardex Group, a company that develops solutions to assess medication adherence by ambulatory patients. Read More

Particle Sciences has expanded its cGMP capabilities with the addition of thin-film technology. Read More

Protalix has received a $25-million milestone payment from Pfizer for the US approval of Elelyso (taliglucerase alfa). Read More

Recipharm has invested in a Dara cartridge-filling machine for injectable solutions at its facility in Monts, Loire Valley, France. The machine features filling volumes between 1.5 and 5 mL, and can operate at speeds up to 7200 cartridges per hour. Read More

SAFC will consolidate its global chiral chromatography screening and small-scale purification operations and locate them at its Pharmorphix solid-state research laboratories in Cambridge, United Kingdom, to support its new integrated chiral chemistry offering. Read More

SGS has opened its cell-based assay laboratory at its facility in Poitiers, France. Read More

Suzhou Pharma Services has announced its new US corporate offices in Lyndhurst, New Jersey, and its new FDA-approved manufacturing facility in Suzhou, China.

People News

Lachman Consultant Services has named David Jaworski as a director in its compliance practice. Read More

SCM Pharma has appointed Paul Thomas as a director for its senior team. Read More

USON has appointed Charles D. Foran Jr. as president.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
20%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
12%
Regulatory compliance
40%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here